Education
MD
- Robert Wood Johnson
Residency
- University of Pennsylvania Medical School
Memberships & Activities
- 1991 American Medical Association
- 1996 American Roentgen Ray Society
- 1996 American Society for Therapeutic Radiology and Oncology
- 1997 American College of Radiology
- 1997 Radiological Society of North America
- 1997 American College of Radiation Oncology
- 1998 American Society of Clinical Oncology
- 1999 American Brachytherapy Society
- 2001 Cancer Survivor Day at Virtua Health System
- 2002–present, Cancer Survivor Day at Main Line Health
- 2003–present, Man to Man through the ACS
- 2011–present, Cancer Survivor Day Cape Regional Medical Center
Awards & Honors
HONORS, AWARDS, CITATIONS
- 1996 Howard H. Wong Fellowship in Radiation Oncology
- 2004 Membership Who’s Who in Medicine and Healthcare
- 2004 Fellowship to The Philadelphia College of Physicians
- 2006, 2007, 2011 Main Line Health Top Doctor
- 2012–present, Philadelphia magazine Top Doctor
- 2012–present, U.S. News and World Report Top Doctor Radiation Oncology
- 2013–present, Castle Connelly Top Doctor
Publications
- Optimal prescription isodose line in SBRT for lung tumor treatment with volumetric-modulated arc therapy. Wang D, DeNittis A, Evans T, Meyer T. J Radiosurg SBRT. 2020;7(2):157-164.
- Steep Dose-response Relationship Between Maximum Hippocampal Dose and Memory Deficits Following Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: A Secondary Analysis of NRG/RTOG 0933. Redmond KJ, Grimm J, … DeNittis AS, et al. International Journal of Radiation Oncology, Biology, Physics. 2020; 108(3);supplement.
- Strategies to optimize stereotactic radiosurgery plans for brain tumors with volumetric-modulated arc therapy. Wang D, DeNittis A, Hu Y. J Appl Clin Med Phys. 2020 Feb 11.
- Gantry-mounted linear accelerator-based stereotactic body radiotherapy for low-and intermediate-risk prostate cancer. Dang A, Levin-Epstein R, Shabsovich D, … DeNittis A, et al. Adv Radiat Oncol. 2019;5(3):404-11.
- Pretreatment volume of MRI-determined white matter injury predicts neurocognitive decline after hippocampal avoidant whole-brain radiation therapy for brain metastases: Secondary analysis of NRG Oncology Radiation Therapy Oncology Group 0933. Bovi J, Pugh S, Sabsevitz D, … DeNittis A, et al. Adv Radiat Oncol. 2019;4(4):579-86.
- Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study. Ahmed A, Deng W, Tew W, Fleming G, DeNittis A. Gynecol Oncol. 2018 Aug;150(2):300-5.
- Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933. Bovi JA, Pugh SL, Sabsevitz D, … DeNittis AS, et al. Adv Radiat Oncol. 2019 Jul 16;4(4):579-86.
- Neoadjuvant chemotherapy and high-dose radiation using intensity-modulated radiotherapy followed by rectal sparing TEM for distal rectal cancer. Parikh K, DeNittis AS, Marks G, Zeger E, Cho D, Marks J. J Radiat Oncol 2019. doi.org/10.1007/s13566-019-00389-9.
- Photon irradiation using a water bath technique for treatment of confluent carcinoma in situ of the hand, digits, and nail bed: a case report. Goodman C, DeNittis A. J Med Case Rep 2017;11(1):86.
- Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools on NRG Oncology RTOG trial 0841. Wagner L, Pugh S, Small W, Kirshner J, … DeNittis A, et al. Cancer 2017;123(3):485-93.
- A randomized phase 2 trial of prophylactic Manuka honey for the reduction of chemoradiation therapy induced esophagitis-during treatment of lung cancer: Results of NRG Oncology RTOG 1012. Fogh S, Deshmukh S, Berk L, …, DeNittis A, et al. Int J Radial Oncol Biol Phys 2017;97(4):786-96.
- Feasibility of patient reporting of symptomatic adverse events via the POR-CTCAE in chemoradiotherapy cooperative group multicenter clinical trial. Basch E, PughS, Dueck A, … DeNittis A, et al. J Rad Oncol Biol Phys 2017;98(2):409-18.
- Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer. Marks J, Meyers E, DeNittis A, et al. Surg Endosc 2017;31(12):5248-57.
- Cogstate computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933. Caine C, Deshmukh S, Gondi V, … DeNittis A, et al. J Neurooncology 2016;126(2):327-36.
- Pretreatment FDG-PET Textural features in stage III non-small cell lung cancer: Secondary Analysis of Acrin 6668/RTOG 0235. Pretreatment FDG-PET Textural features in stage III non-small cell lung cancer: secondary analysis of Acrin 6668/RTOG 0235. Ohri N, Duan F, Snyder B … DeNittis A, et al. J Nucl Med 2016:57(6);842-8.
- Linac-based SBRT delivered in 5 fractions for prostate cancer using VMAT: a phase II experience evaluating survival and quality of life. DeNittis A, Wang Y, Orisamolu A, et al. J Rad Oncol 2016 May 14.
- Metabolic tumor volume on FDG-PET predicts clinical outcomes following chemoradiotherapy for locally advanced non-small cell lung cancer: A secondary analysis of ACRIN 6668/RTOG 0235. Ohri N, Duan F, Machtay M, … DeNittis AS, et al. JNCI 2015;7(4).
- Metabolic tumor volume on FDG-PET predicts clinical outcomes following chemoradiotherapy for locally advanced non-small cell lung cancer: A secondary analysis of ACRIN 6668/RTOG 0235. Ohri N, Duan F, Machtay M, … DeNittis AS, et al. JNCI 2015;7(4).
- Radiation Therapy Oncology Group 0822: A phase II study of preoperative chemoradiotherapy utilizing intensity modulated radiation therapy (IMRT) in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer. Hong T, Moughan J, Garofalo M, … DeNittis A, et al. Int J of Rad Oncol Biol Phys 2015;93(1):29-36.
- Preservation of memory with conformal avoidance of the hippocampus neural stem cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): A phase II multi-institutional trial. Gondi V, Pugh S, Tome W, DeNittis A, et al. J Clin Oncol 2014;32(34):3810-6.
- Prediction of survival by FDG-PET in patients with locally advanced non-small cell lung cancer undergoing definitive chemoradiation therapy: Results of the ACRIN 6668/RTOF 0235 Trial. Machtay M, Duan F, Siegel B, … DeNittis A, et al. J Clin Oncol 2013;31(30):3823-30.
- Sphincter sparing surgery for the distal 3 cm of the true rectum: Results after neoadjuvant therapy and minimally invasive radical surgery or local excision. Marks J, Nassif G, Schoonyoung H, … DeNittis A, et al. Surg Endosc 2013;27(12):4469-77.
- A bioactive probe of the oxidative pentose phosphate cycle: novel strategy to reverse radioresistance in glucose deprived human colon cancer cells. Li J, Ward K,Zhang D, Dayanandam E, DeNittis AS, Prendergrast G, Ayene I. Toxicol in Vitro 2013;27(1):367-77.
- Transanal Endoscopic Microsurgery (TEM) for treatment of rectal cancer: Comparison of wound complication rate with and without neoadjuvant radiation therapy. Marks J, Valsdottir E, DeNittis A, et al. Surgl Endosc 2009;23:1080-87.
- Surgical decision making should be based on the downstaged rectal cancer following neoadjuvant therapy. Marks J, Valsdotter EB, DeNittis A, et al. Annuls of Surgical Oncology 2009;23(5).
- Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: Oncologic outcome and functional assessment. DeNittis A, Machtay M, Rosental D, et al. Am J Otolaryngol 2001;22(5):329-35.